Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Li Auto Inc (LI) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance

Li Auto IncTrade
DENTSPLY SIRONA IncTrade

Price performance (Past 24H)

Key statistics

Li Auto Inc vs DENTSPLY SIRONA Inc — how do they compare? Li Auto Inc trades at $11.53 (market cap $10.71B), while DENTSPLY SIRONA Inc trades at $8.82 (market cap $1.73B). The key difference: Li Auto Inc is far larger — about 6.2× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Li Auto Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Li Auto Inc for 101 Days and DENTSPLY SIRONA Inc for 72 Days on average.

LIXRAY
Market Cap
$10.71B$1.73B
Volume
1,781,1436,198,582
Sector
Consumer CyclicalHealth
52-Week High
$23.61$14.68
52-Week Low
$10.69$8.52
Typical Hold Time
101 Days72 Days
Enterprise Value
$139.58M$3.80B
Dividend Yield
—5.04%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Li Auto Inc

Li Auto (LI) trades at $11.54, down 5.0% recently and near 52-week lows amid weak delivery numbers. The stock shows bearish technical signals with negative moving averages, while fundamentals reveal declining revenue from $144.5B in 2024 to $112.3B in 2025 and negative net income margins. Recent news highlights September deliveries of 31,817 vehicles and new model launches like the Li i9 SUV.

Outlook remains challenging with intense EV competition and cash flow concerns, though analyst consensus suggests 32% upside to $15.18 target. Key risks include execution on new models and Chinese market volatility, while the strong balance sheet provides some stability for patient investors.

DENTSPLY SIRONA Inc

DENTSPLY SIRONA (XRAY) trades at $8.83, down 3.4% with bearish technical signals. The stock faces fundamental challenges with negative net income margins (-14.99%) and declining revenue trends ($3.68B in 2025). Recent Q2 2026 earnings beat expectations but sales fell 4.1% amid ongoing turnaround efforts. The company maintains strong institutional interest despite hitting 52-week lows in September 2026.

XRAY presents a high-risk opportunity with Wall Street maintaining a cautious stance (37.5% buy rating). The consensus price target of $13.40 offers 52% upside potential, but investors face execution risks in the dental equipment turnaround, margin pressures, and competitive challenges. Near-term catalysts include management's presentation at the Baird Healthcare Conference in September 2026.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LI
50% Buy50% Sell
Avg holding period · 101 Days
XRAY

No sentiment data available yet.

About Li Auto Inc

Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 90,000 EVs in 2021, accounting for about 2.7% of China's passenger new energy vehicle market. Beyond Li One, the company will expand its product line, including both BEVs and PHEVs, to target a broader consumer base.

Read more on LI →

About DENTSPLY SIRONA Inc

Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters

Read more on XRAY →